http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012154582-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82B1-00 |
| filingDate | 2012-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012154582-A |
| titleOfInvention | METHOD FOR SELECTING ACNE TREATMENT IN WOMEN |
| abstract | The method of choosing the treatment of acne in women by examining biological fluids and prescribing drugs depending on the results of the examination, characterized in that blood and urine are used as biological fluids, laboratory determination of blood serum hormones, steroid profile of urine and comparison of the obtained parameters with predefined standard characteristic for the absence of acne, and the appointment of drugs is carried out according to the results of comparison: with an increase in the blood level of luteinizing hormones up to 16 mIU / ml, testosterone - up to 4 ng / ml, an increase in the level of androsterone in the urine - up to 20 μmol / 24 hours, etiocholanolone - up to 11 μmol / 24 hours, the sum of 17 - ketosteroids - up to 35 μmol / 24 hours, discriminants van de Calceide, up to 3 - combined oral contraceptive with anti-androgenic effect of Jess, and with an increase in levels of immunoreactive insulin - up to 12.90 mcED / ml and insulin-like growth factor 1 to 361.04 ng / ml - combined oral contraceptive with anti-androgenic effect of Jes and metformin or metformin; with a decrease in blood levels of estradiol to 140 pmol / L and an increase in the concentration of luteinizing hormone to 7 mIU / ml, dihydroepiandrosterone sulfate - up to 4 mmol / l, 17 - hydroxyprogesterone - up to 4 nmol / l and testosterone - up to 4 nmol / l in the blood and an increase in urine levels of androsterone to 17 μmol / 24 hours, etiocholanolone - up to 17 μmol / 24 hours, 11 - ketoandrosterone - up to 2.5 μmol / 24 hours, 11 - ketoethiocholanolone - up to 2.5 μmol / 24 hours, 17 - ketosteroids - up to 50 μmol / 24 hours and discriminants of van de Calseide up to 3 - prescribed glucocorticosteroid - metipred; with a decrease in blood levels of sex steroids |
| priorityDate | 2012-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.